Abbott Announces Increase in Quarterly Dividend

Abbott Declares 364th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Dec. 12, 2014 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to $0.24 per share from $0.22 per share.

This marks the 364th consecutive quarterly dividend to be paid by Abbott since 1924.  The cash dividend is payable Feb. 13, 2015, to shareholders of record at the close of business on Jan. 15, 2015.

This will mark the 43rd consecutive year the company has increased its dividend payout. Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbott-announces-increase-in-quarterly-dividend-300009085.html

SOURCE Abbott

Suggested Articles

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.

In a last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat rivals.